We are recruiting!

The individual ESR projects are designed to provide appropriate research goals for PhD students, which will result in the completion of a research thesis, publications and in the dissemination of the scientific results at international conferences.

Each of the 15 ESRs will be exposed to a well-balanced and optimal experience in academia, industry and research centre in order to increase their research experience and scientific maturity. They will also gain broader experience from spending time in Partner research labs, experiencing different research environments and cultures, and producing well-rounded ‘European’ scientists. Their training will be undertaken in some of the world`s key laboratories for polymer research and in innovative European companies.

All open positions will be published on EURAXESS

 

ESR1: Fully degradable glycopolypeptide nanoparticles for the delivery of active compounds

Host institution:

Royal College of Surgeons in Ireland, Dublin, Ireland

Planned Secondments:

University of Warwick, Coventry, United Kingdom (2 months)

Ludger Ltd., Oxfordshire, United Kingdom (2 months)


ESR2: Glycopolypeptide grafted silica nanoparticles and their biological interaction

Host institution:

Royal College of Surgeons in Ireland, Dublin, Ireland

Planned Secondments:

MJR PharmJet GmbH, Überherrn, Germany (2 months)

University of Warwick, Coventry, United Kingdom (2 months)


ESR3: Glyco-nanoparticle libraries based on gold/polymer hybrids

Host institution:

University of Warwick, Coventry, United Kingdom

Planned Secondments:

Ludger Ltd., Oxfordshire, United Kingdom (3 months)

Royal College of Surgeons in Ireland, Dublin, Ireland (3 months)


ESR4: Synthesis of smart glycosides to enhance the glyco-nanomaterial circulation half-life

Host institution:

Università degli Studi di Milano, Milan, Italy

Planned Secondments:

Midatech Ltd., Abingdon, United Kingdom (2 months)

Royal College of Surgeons in Ireland, Dublin, Ireland (3 months)


ESR5: Glycan-coated nanoparticles for the enhanced delivery of bioactive compounds

Host institution:

Midatech Ltd., Abingdon, United Kingdom

Planned Secondments:

Royal College of Surgeons in Ireland, Dublin, Ireland (3 months)

Vlaamse Instelling voor Technologisch Onderzoek N.V., Mol, Belgium (2 months)


ESR6: Development of purification and modification strategies of N-type glycopeptide and glycan moieties for use as nanoparticle activity enhancers

Host institution:

Ludger Ltd., Oxfordshire, United Kingdom

Planned Secondments:

University of Warwick, Coventry, United Kingdom (3 months)

Royal College of Surgeons in Ireland, Dublin, Ireland (4 months)


ESR7: Development of synthetic and natural nano-glycomaterials with defined corona for enhanced blood circulation and low immunogenicity

Host institution:

Royal College of Surgeons in Ireland, Dublin, Ireland

Planned Secondments:

Ludger Ltd., Oxfordshire, United Kingdom (4 months)

CIC biomaGUNE, San Sebastian, Spain (4 months)


ESR8: Biological analysis of lecting binding capacity

Host institution:

University of Warwick, Coventry, United Kingdom

Planned Secondments:

Midatech Ltd., Abingdon, United Kingdom (3 months)

CIC biomaGUNE, San Sebastian, Spain (3 months)


ESR9: In vitro studies of the stability of protein corona around glyco NPs and biological fate

Host institution:

CIC biomaGUNE, San Sebastian, Spain

Planned Secondments:

Midatech Ltd., Abingdon, United Kingdom (3 months)

Royal College of Surgeons in Ireland, Dublin, Ireland (3 months)


ESR10: In vitro biocompatibility assay for glyconano-conjugates

Host institution:

Royal College of Surgeons in Ireland, Dublin, Ireland

Planned Secondments:

Attana AB, Stockholm, Sweden (6 months)

University of Warwick, Coventry, United Kingdom (3 months)


ESR11: Biosensing platform for lectin detection related to cerebrovascular disease using nanoplasmonics

Host institution:

Vlaamse Instelling voor Technologisch Onderzoek N.V., Mol, Belgium

Planned Secondments:

University of Warwick, Coventry, United Kingdom (2 months)

Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy (4 months)


ESR12: Evaluation and optimisation of glycan-coated gold nanoparticles for selective accumulation to tumour tissue

Host institution:

Midatech Ltd., Abingdon, United Kingdom

Planned Secondments:

Royal College of Surgeons in Ireland, Dublin, Ireland (4 months)

Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy (4 months)


ESR13: Glycan-coated nanoparticles as inhibitors of specific lectins, a new neuroprotective therapeutic strategy for brain injury caused by ischemia

Host institution:

Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy

Planned Secondments:

Università degli Studi di Milano, Milan, Italy (2 months)

Attana AB, Stockholm, Sweden (3 months)


ESR14: In vivo fate studies of glyco NPs and biocorona stability

Host institution:

CIC biomaGUNE, San Sebastian, Spain

Planned Secondments:

Università degli Studi di Milano, Milan, Italy (2 months)

Vlaamse Instelling voor Technologisch Onderzoek N.V., Mol, Belgium (3 months)


ESR15: Evaluation of the role of surface functionalization of Glyco-NP on the distribution, excretion and crossing of biological barriers in healthy and pathologic mice

Host institution:

Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy

Planned Secondments:

Royal College of Surgeons in Ireland, Dublin, Ireland (3 months)

Vlaamse Instelling voor Technologisch Onderzoek N.V., Mol, Belgium (3 months)